Lawrence P. Wennogle Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Lawrence P. Wennogle.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Lawrence P. Wennogle. Lawrence P. Wennogle is a Vice President, Drug Discovery in Intra-Cellular Therapies, Inc. ($ITCI).

Address: C/O INTRA-CELLULAR THERAPIES, INC. 3960 BROADWAY NEW YORK 10032 NY

Companies in which Lawrence P. Wennogle is an Insider

Intra-Cellular Therapies, Inc.

Trading Symbol: ITCI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Lawrence P. Wennogle: Vice President, Drug Discovery
Holdings: 126,500 shares
Current Value: $1,839,310
Latest Transaction: Jun 09 2015
$ITCI Market Capitalization: $607.92M
$ITCI Previous Close: $14.54

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Lawrence P. Wennogle

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 09 2015ITCIIntra-Cellular The ...Wennogle Lawrence P.Vice President, Dru ...SellS26.8425,000671,000126,500151.5 K to 126.5 K (-16.50 %)
May 20 2015ITCIIntra-Cellular The ...Wennogle Lawrence P.Vice President, Dru ...Option ExerciseM1.5010,00015,0000
May 20 2015ITCIIntra-Cellular The ...Wennogle Lawrence P.Vice President, Dru ...Option ExerciseM1.5012,50018,7500
May 20 2015ITCIIntra-Cellular The ...Wennogle Lawrence P.Vice President, Dru ...Option ExerciseM1.3612,50017,0000
May 20 2015ITCIIntra-Cellular The ...Wennogle Lawrence P.Vice President, Dru ...Option ExerciseM0.6012,5007,5000
May 20 2015ITCIIntra-Cellular The ...Wennogle Lawrence P.Vice President, Dru ...BuyM1.5010,00015,000151,500141.5 K to 151.5 K (+7.07 %)
May 20 2015ITCIIntra-Cellular The ...Wennogle Lawrence P.Vice President, Dru ...BuyM1.5012,50018,750141,500129 K to 141.5 K (+9.69 %)

View all Lawrence P. Wennogle insider transactions.